$BIIB Company News
Post# of 94281
Posted On: 04/22/2014 11:18:06 AM
$BIIB Company News
Apple, Microsoft are not the keys to this week’s news
7:00 a.m. Today7:00 a.m. April 22, 2014
- Marek Fuchs
Long view on stocks is best during weak earnings season
6:00 a.m. April 20, 2014
- Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground
4:58 p.m. April 14, 2014
- blogs.marketwatch.com
Herbalife sinks on probe fears; Zoe’s surges on debut
4:36 p.m. April 11, 2014
- Ben Eisen
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap
4:11 p.m. April 7, 2014
- blogs.marketwatch.com
Biotech bargain?
11:43 a.m. April 1, 2014
- The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch
5:21 a.m. March 31, 2014
- Victor Reklaitis
U.S. stocks end week with losses
7:17 p.m. March 28, 2014
- Anora Mahmudova
Nasdaq pullback rife with opportunity
2:07 p.m. March 25, 2014
- The Trading Deck
Biotech comeback stalls as Wall Street starts to worry
12:45 p.m. March 25, 2014
- blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2%
4:40 p.m. March 24, 2014
- Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin
10:40 a.m. March 24, 2014
- blogs.marketwatch.com
First Solar extends winning streak; Symantec plunges
3:06 p.m. March 21, 2014
- Ben Eisen
Investors let air out of biotech amid overheating, pricing concerns
1:42 p.m. March 21, 2014
- blogs.marketwatch.com
U.S. stocks rise; S&P 500 positive for the year
4:39 p.m. March 17, 2014
- Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum
4:17 p.m. March 17, 2014
- Saumya Vaishampayan
Keurig Green Mountain added to S&P 500 index
9:56 a.m. March 15, 2014
- MarketWatch.com
From every angle, technicals point to richer stocks
2:25 p.m. March 11, 2014
- The Trading Deck
Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap
4:03 p.m. March 7, 2014
- blogs.marketwatch.com
Best stocks for legalized marijuana
1:37 p.m. Feb. 27, 2014
- blogs.marketwatch.com
Insider Trading Alert - BIIB, JAZZ And KWK Traded By Insiders
10:15 a.m. Today10:15 a.m. April 22, 2014
- TheStreet.com
Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape
9:39 a.m. Today9:39 a.m. April 22, 2014
- Zacks.com
Zacks Rank #1 Additions for Tuesday - Tale of the Tape
9:30 a.m. Today9:30 a.m. April 22, 2014
- Zacks.com
Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% - Tale of the Tape
8:51 a.m. Today8:51 a.m. April 22, 2014
- Zacks.com
ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape
8:44 a.m. Today8:44 a.m. April 22, 2014
- Zacks.com
Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape
8:41 a.m. Today8:41 a.m. April 22, 2014
- Zacks.com
Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog
6:20 p.m. April 21, 2014
- Zacks.com
Biotech Is Not A Popping Bubble: Buy The Dip While You Can
2:34 p.m. April 21, 2014
- Seeking Alpha
Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog
10:50 a.m. April 21, 2014
- Zacks.com
Gilead heads Citi's 20 best stocks in America
10:28 a.m. April 21, 2014
- Seeking Alpha
3 Stocks Reiterated As A Buy: MU, VZ, BIIB
9:59 a.m. April 21, 2014
- TheStreet.com
Today's Market: Other Potential Buyout Targets For Pfizer
8:54 a.m. April 21, 2014
- Seeking Alpha
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; Amunix Could Recieve up to $39M
7:02 a.m. April 21, 2014
- benzinga.com
Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings
11:12 a.m. April 18, 2014
- Investors Business Daily
Xenoport's Path Is Long, But The Potential Is There
8:31 p.m. April 17, 2014
- Seeking Alpha
AbbVie Candidate in Pivotal Study - Analyst Blog
12:32 p.m. April 17, 2014
- Zacks.com
Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings
9:18 a.m. April 17, 2014
- TheStreet.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
10:07 a.m. April 16, 2014
- Zacks.com
'Fast Money' Recap: Impressed by Yahoo!
5:00 a.m. April 16, 2014
- TheStreet.com
Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog
11:30 a.m. April 15, 2014
- Zacks.com
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor
VIII
8:02 a.m. April 21, 2014
- Marketwire
RBCC Bioprinting Partner Expands Brand Awareness Campaign
4:28 a.m. April 16, 2014
- BusinessWire - BZX
Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
1:00 p.m. April 15, 2014
- PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept
8:00 a.m. April 15, 2014
- PR Newswire - PRF
Biogen Idec to Present New Clinical Data from Its Robust Neurology
Portfolio at AAN Annual Meeting
7:30 a.m. April 14, 2014
- BusinessWire - BZX
JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business
12:36 a.m. April 14, 2014
- ACCESSWIRE
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George
Scangos Assume New Posts
9:00 a.m. April 11, 2014
- BusinessWire - BZX
Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
7:30 a.m. April 10, 2014
- BusinessWire - BZX
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A
7:06 a.m. April 10, 2014
- Thomson Reuters ONE
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety
Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™
(rFVIIIFc) for Hemophilia A
7:00 a.m. April 10, 2014
- BusinessWire - BZX
RBCC and n3D Seek Out Additional Capital
5:00 a.m. April 9, 2014
- BusinessWire - BZX
Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
8:00 a.m. April 8, 2014
- PR Newswire - PRF
Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution
5:00 a.m. April 3, 2014
- BusinessWire - BZX
Biogen Idec to Report First Quarter 2014 Financial Results on April
23, 2014
4:01 p.m. March 31, 2014
- BusinessWire - BZX
Sobi: US FDA approves Alprolix(TM)
2:05 a.m. March 31, 2014
- GlobeNewswire
Sobi: US FDA approves Alprolix(TM)
2:01 a.m. March 31, 2014
- Thomson Reuters ONE
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:34 p.m. March 28, 2014
- BusinessWire - BZX
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:24 p.m. March 28, 2014
- BusinessWire - BZX
Critical Alerts For DirecTV, Biogen Idec, Time Warner, Isis Pharmaceuticals, and DreamWorks Animation Released By InvestorsObserver
9:31 a.m. March 27, 2014
- PR Newswire - PRF
Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
12:11 p.m. March 26, 2014
- PR Newswire - PRF
Apple, Microsoft are not the keys to this week’s news
7:00 a.m. Today7:00 a.m. April 22, 2014
- Marek Fuchs
Long view on stocks is best during weak earnings season
6:00 a.m. April 20, 2014
- Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground
4:58 p.m. April 14, 2014
- blogs.marketwatch.com
Herbalife sinks on probe fears; Zoe’s surges on debut
4:36 p.m. April 11, 2014
- Ben Eisen
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap
4:11 p.m. April 7, 2014
- blogs.marketwatch.com
Biotech bargain?
11:43 a.m. April 1, 2014
- The Trading Deck
Facebook, Biogen, Cal-Maine are stocks to watch
5:21 a.m. March 31, 2014
- Victor Reklaitis
U.S. stocks end week with losses
7:17 p.m. March 28, 2014
- Anora Mahmudova
Nasdaq pullback rife with opportunity
2:07 p.m. March 25, 2014
- The Trading Deck
Biotech comeback stalls as Wall Street starts to worry
12:45 p.m. March 25, 2014
- blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2%
4:40 p.m. March 24, 2014
- Anora Mahmudova
Biotech has second straight sell-off; sector mutual funds take it on chin
10:40 a.m. March 24, 2014
- blogs.marketwatch.com
First Solar extends winning streak; Symantec plunges
3:06 p.m. March 21, 2014
- Ben Eisen
Investors let air out of biotech amid overheating, pricing concerns
1:42 p.m. March 21, 2014
- blogs.marketwatch.com
U.S. stocks rise; S&P 500 positive for the year
4:39 p.m. March 17, 2014
- Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum
4:17 p.m. March 17, 2014
- Saumya Vaishampayan
Keurig Green Mountain added to S&P 500 index
9:56 a.m. March 15, 2014
- MarketWatch.com
From every angle, technicals point to richer stocks
2:25 p.m. March 11, 2014
- The Trading Deck
Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap
4:03 p.m. March 7, 2014
- blogs.marketwatch.com
Best stocks for legalized marijuana
1:37 p.m. Feb. 27, 2014
- blogs.marketwatch.com
Insider Trading Alert - BIIB, JAZZ And KWK Traded By Insiders
10:15 a.m. Today10:15 a.m. April 22, 2014
- TheStreet.com
Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape
9:39 a.m. Today9:39 a.m. April 22, 2014
- Zacks.com
Zacks Rank #1 Additions for Tuesday - Tale of the Tape
9:30 a.m. Today9:30 a.m. April 22, 2014
- Zacks.com
Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% - Tale of the Tape
8:51 a.m. Today8:51 a.m. April 22, 2014
- Zacks.com
ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape
8:44 a.m. Today8:44 a.m. April 22, 2014
- Zacks.com
Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape
8:41 a.m. Today8:41 a.m. April 22, 2014
- Zacks.com
Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog
6:20 p.m. April 21, 2014
- Zacks.com
Biotech Is Not A Popping Bubble: Buy The Dip While You Can
2:34 p.m. April 21, 2014
- Seeking Alpha
Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog
10:50 a.m. April 21, 2014
- Zacks.com
Gilead heads Citi's 20 best stocks in America
10:28 a.m. April 21, 2014
- Seeking Alpha
3 Stocks Reiterated As A Buy: MU, VZ, BIIB
9:59 a.m. April 21, 2014
- TheStreet.com
Today's Market: Other Potential Buyout Targets For Pfizer
8:54 a.m. April 21, 2014
- Seeking Alpha
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; Amunix Could Recieve up to $39M
7:02 a.m. April 21, 2014
- benzinga.com
Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings
11:12 a.m. April 18, 2014
- Investors Business Daily
Xenoport's Path Is Long, But The Potential Is There
8:31 p.m. April 17, 2014
- Seeking Alpha
AbbVie Candidate in Pivotal Study - Analyst Blog
12:32 p.m. April 17, 2014
- Zacks.com
Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings
9:18 a.m. April 17, 2014
- TheStreet.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
10:07 a.m. April 16, 2014
- Zacks.com
'Fast Money' Recap: Impressed by Yahoo!
5:00 a.m. April 16, 2014
- TheStreet.com
Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog
11:30 a.m. April 15, 2014
- Zacks.com
Biogen Idec Signs License Agreement With Amunix for XTENylated Factor
VIII
8:02 a.m. April 21, 2014
- Marketwire
RBCC Bioprinting Partner Expands Brand Awareness Campaign
4:28 a.m. April 16, 2014
- BusinessWire - BZX
Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
1:00 p.m. April 15, 2014
- PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept
8:00 a.m. April 15, 2014
- PR Newswire - PRF
Biogen Idec to Present New Clinical Data from Its Robust Neurology
Portfolio at AAN Annual Meeting
7:30 a.m. April 14, 2014
- BusinessWire - BZX
JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business
12:36 a.m. April 14, 2014
- ACCESSWIRE
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George
Scangos Assume New Posts
9:00 a.m. April 11, 2014
- BusinessWire - BZX
Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
7:30 a.m. April 10, 2014
- BusinessWire - BZX
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A
7:06 a.m. April 10, 2014
- Thomson Reuters ONE
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety
Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™
(rFVIIIFc) for Hemophilia A
7:00 a.m. April 10, 2014
- BusinessWire - BZX
RBCC and n3D Seek Out Additional Capital
5:00 a.m. April 9, 2014
- BusinessWire - BZX
Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
8:00 a.m. April 8, 2014
- PR Newswire - PRF
Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution
5:00 a.m. April 3, 2014
- BusinessWire - BZX
Biogen Idec to Report First Quarter 2014 Financial Results on April
23, 2014
4:01 p.m. March 31, 2014
- BusinessWire - BZX
Sobi: US FDA approves Alprolix(TM)
2:05 a.m. March 31, 2014
- GlobeNewswire
Sobi: US FDA approves Alprolix(TM)
2:01 a.m. March 31, 2014
- Thomson Reuters ONE
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:34 p.m. March 28, 2014
- BusinessWire - BZX
FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:24 p.m. March 28, 2014
- BusinessWire - BZX
Critical Alerts For DirecTV, Biogen Idec, Time Warner, Isis Pharmaceuticals, and DreamWorks Animation Released By InvestorsObserver
9:31 a.m. March 27, 2014
- PR Newswire - PRF
Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
12:11 p.m. March 26, 2014
- PR Newswire - PRF
(0)
(0)